Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gordon Carmichael currently holds 40,000 shares of GYRE THERAPEUTICS, INC. (GYRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gordon Carmichael has been a net neutral trader of GYRE stock. They have purchased $0 and sold $0 worth of shares.
Gordon Carmichael's most recent insider trade was on Jun 10, 2026, when they sold 40,000 shares at $0.00 per share.
Gordon Carmichael serves as Executive at GYRE THERAPEUTICS, INC. (GYRE). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Gordon Carmichael holds the position of Executive at GYRE THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gordon Carmichael has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gordon Carmichael was on Jun 10, 2026, when they purchased $0 worth of GYRE shares. This transaction involved 40,000 shares at N/A per share.
Gordon Carmichael currently owns 40,000 shares of GYRE THERAPEUTICS, INC. (GYRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gordon Carmichael's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gordon Carmichael has 2 Form 4 filings on record as an insider at GYRE THERAPEUTICS, INC..
Set alerts for Gordon Carmichael and 40,000+ other insiders.